Key Takeaways Pfizer's deal with Trump cuts drug prices, boosts U.S. investment and lifts pharma sector sentiment.Investor optimism grows as major drugmakers eye similar tariff-free pricing agreements with Trump.J&J, Bayer and Novartis show strong growth momentum, making them attractive pharma investment picks.Late last month, Pfizer (PFE) announced a landmark deal with the Trump administration to cut drug prices and expand U.S. innovation and manufacturing.Under the deal, Pfizer agreed to slash prices of s ...

Next Tuesday and Wednesday are poised to be major market-moving days, with a heavy concentration of financials earnings. Next Tuesday pre-market, major banks including JPMorgan Chase & Co., Wells Fargo & Company, Goldman Sachs Group Inc. (The), and Citigroup Inc. are set to report, alongside healthcare giant Johnson & Johnson. The earnings density continues into Next Wednesday pre-market with Bank of America Corporation and Morgan Stanley, joined by semiconductor leader ASML Holding N.V. and real estate maj ...

据法庭文件，强生正面临来自逾6.7万名原告的诉讼，这些原告均称在使用婴儿爽身粉后确诊癌症，其中绝大多数涉及卵巢癌索赔，只有小部分指控滑石粉 产品致间皮瘤。过去一年，强生在多起间皮瘤案件中被判高额赔偿，而本次判决是单一原告获赔金额最高的一起判决。 为了应对涉爽身粉的大规模诉讼，强生公司选择采用了"得州两步破产法"（Texas two-step bankruptcy），即将其爽身粉负债剥离到子公司，然后再为子公司 申请破产保护，以此规避赔偿问题。该策略虽然被反对声音认为属于含有欺诈性转移资产的恶意破产，违反美国破产法，但目前美国已存在多个涉及石棉诉 讼后的成功"两步走"案例。 强生此前曾表示，该公司的"两步走"方案得到了83%的索赔人的支持，高于美国破产法规定的75%的要求。不过，今年3月底，美国法官第三次驳回强生方 案时表示，强生"为数千名债权人提供了不合理的短投票时间，而且不惜一切代价达到75%的比例"。 当地时间10月6日，美国洛杉矶一个陪审团认定强生公司（Johnson & Johnson）在最新一起指控其婴儿爽身粉致癌的诉讼中负有责任，因此须向一名因"间皮 瘤"去世女子的家属支付9.66亿美元（约合68 ...

Pfizer Inc. NYSE: PFE made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of around $23.61 on Sept. 25. Pfizer TodayPFEPfizer$26.27 -0.16 (-0.61%) 52-Week Range$20.92▼$30.43Dividend Yield6.55%P/E Ratio13.97Price Target$28.41Add to WatchlistThis is welcome news to long-term holders who have endured a significant dip in the stock since its vaccine-fueled surge in 2021. PFE stock trades at an attra ...

Johnson & Johnson (NYSE:JNJ) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Johnson & Johnson (JNJ): A Cornerstone Among the Most Profitable Dividend Stocks Johnson & Johnson (NYSE:JNJ) is one of America’s most recognizable healthcare companies, with operations that now center on pharmaceuticals and medical devices. After spinning off its consumer health unit, which included familiar names like Tylenol, Neutrogena, and Listerine, into a separate company called Kenvue, the comp ...

These two market leaders have increased their dividends for a combined 115 years.It's impossible to predict with certainty whether a recession is coming, but certain developments sure make it more likely. President Donald Trump's tariff policies could lead to increased prices and plunge the economy into a downturn. The recent government shutdown, especially if it drags on, could lead us directly into a recession.Of course, that may not happen, but it's not a bad idea for investors to prepare for that possib ...

LOS ANGELES--(BUSINESS WIRE)--A Los Angeles County jury has returned damages totaling $966 million, including $950 million in punitive damages, to the family of Mae Moore, who died of mesothelioma in 2021 after using Johnson & Johnson's iconic baby powder. Lawyers for the family say this is the largest verdict ever against Johnson & Johnson in a mesothelioma case linked to talc products. Ms. Moore, the wife of a pastor and a mother of three, regularly used Johnson & Johnson's baby p. ...

Johnson & Johnson was told by a California jury to pay $966 million to the family of a deceased woman who blamed her cancer on life-long use of the company’s baby powder in the largest verdict for a single user in the 15-year litigation. https://t.co/SnXMLNhmqL ...

The family of The verdict could be reduced on appeal as the Erik Haas, Johnson & Johnson's worldwide vice president of litigation, said in a statement that the company plans to immediately appeal, calling the verdict "egregious and unconstitutional." "The plaintiff lawyers in this Moore case based their arguments on 'junk science' that never should have been presented to the jury," Haas said.Live Events The company has said its products are safe, do not contain asbestos, and do not cause cancer. J&J stop ...

A Los Angeles jury late on Monday ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest lawsuit alleging its baby powder products cause cancer.The family of Mae Moore, who died in 2021, sued the company the same year, claiming Johnson & Johnson’s talc baby powder products contained asbestos fibers that caused her rare cancer. The jury ordered the company to pay $16 million in compensatory damages and $950 million in puniti ...